← Leaderboards
Hao Chen
Novascreen Biosciences Corporation
$5,996,026
Attributed
$5,996,026
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,996,026 · 7
By mechanism
R44$4,773,118 · 2
R43$1,222,908 · 5
Top collaborators
No co-investigators on record.
Most similar at Novascreen Biosciences Corporation
Same institution · by research overlap
- Arthur David Weissman$1,026,948
- Ming Liu$100,000
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionDrug InteractionsDrug Addiction AntagonistPharmacologyCocaineBasePharmaceutical PreparationsBrainReceptor BindingChemical BindingDopamineReuptakeDrug Adverse EffectData CollectionDoseChemical Information SystemInteractive MultimediaChemical Structure FunctionCohortAnimalsAnimal ModelClinicCellsBehavior
Grant awards (12)
Using ACT01 - DHA combination to Improve Conditions of FXS$532,431
R43 · FY2019 · NS · contact PI
Assessment of Dopaminergic Impact and Development of Clinical Biomarker for Fragile X Syndrome$192,852
R43 · FY2016 · NS · contact PI
DAT Selective Inhibitor As Cocaine Medication$858,204
R44 · FY2007 · DA · contact PI
DAT Selective Inhibitor As Cocaine Medication$881,909
R44 · FY2006 · DA · contact PI
Targeting Serotonin and Opioid to Treat Alcoholism$454,986
R44 · FY2006 · AA · contact PI
DAT Selective Inhibitor As Cocaine Medication$922,578
R44 · FY2005 · DA
Targeting Serotonin and Opioid to Treat Alcoholism$460,715
R44 · FY2005 · AA
Identification of Targets for Cystic Fibrosis$204,929
R43 · FY2005 · HL
Profiling DataBase for Cocaine Medications$625,156
R44 · FY2003 · DA
Novel Molecules to Treat Alcoholism$191,343
R43 · FY2003 · AA
Profiling DataBase for Cocaine Medications$569,570
R44 · FY2002 · DA
PROFILING DATA BASE FOR COCAINE MEDICATION$101,353
R43 · FY2000 · DA